top of page
Selected Publications
2025
Ponzo M, et al Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance. J Immunother Cancer. 2025 Oct 23;13(10):e011768
Lussana F and Magnani CF, et al Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. Blood Cancer J. 2025 Apr 3;15(1):54
2024
Volta L, et al Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells. Leukemia. 22024 Dec;38(12):2598-2613
2023
Magnani CF, et al Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cells. Mol Ther Oncolytics. 2023 Jul 19:30:56-71
Bonini C, et al Genome Editing in Engineered T Cells for Cancer Immunotherapy. Hum Gene Ther. 2023 Sep;34(17-18):853-869
2022
Moretti A, et al The past, present, and future of non-viral CAR T cells. Front Immunol. 2022 Jun 9:13:867013
2020
Magnani CF, et al Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. J Clin Invest. 2020 Nov 2;130(11):6021-6033
bottom of page